Shengxiang Biotech: has obtained CE certification for the Nipah virus nucleic acid test kit and domestic research version test kit.

Shengxiang Biology expressed on the interactive platform that the company is continuously deepening its international presence, with Southeast Asia and South Asia being important markets for the company's localized operations and channel development. With the recent outbreak of Nipah virus in India, the company has actively connected with local market channels and business demands, maintained contact with local health authorities, disease control centers, and other medical institutions, and responded quickly to the new public health emergency. Based on the fluorescent PCR technology platform, the company has developed corresponding testing solutions, including Nipah virus nucleic acid testing kits with CE certification and domestic research-grade reagent kits. The product features rapid testing, a fully pre-mixed system, easy operation, built-in endogenous internal controls to effectively prevent false negatives, and excellent core advantages such as specificity and sensitivity. Currently, the related products are ready and compatible with mainstream PCR instruments domestically and internationally. The company will continue to closely monitor the development of the Nipah virus outbreak and market demands to support global public health initiatives.